Dril-Quip, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Dril-Quip, Inc. (“Dril-Quip” or the “Company”)(NYSE: DRQ). Click here to join the investigation…. Read MoreJoin Investigation
Axos Financial, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Axos Financial, Inc. (“Axos” or the “Company”) (NYSE: AX). Click here to join the investigation…. Read MoreJoin Investigation
Autodesk, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Autodesk, Inc. (“Autodesk” or the “Company”) (NASDAQ: ADSK) securities between June 1, 2023 and April 16, 2024 (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
Compass Minerals International, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Compass Minerals International, Inc. (“Compass Minerals” or the “Company”) (NYSE: CMP) securities between November 29, 2023 and March 22, 2024 (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
AST SpaceMobile, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of AST SpaceMobile, Inc. (“SpaceMobile” or the “Company”) (NASDAQ: ASTS) securities between November 14, 2023 and April 1, 2024 (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
Sharecare, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Sharecare, Inc. (“Sharecare” or the “Company”) (NASDAQ: SHCR) securities between May 10, 2023 and March 28, 2024 (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
Evolv Technologies, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Ocugen, Inc.(“Ocugen” or the “Company”) (NASDAQ: OCGN) securities between May 8, 2020 and April 1, 2024 (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
Checkpoint Therapeutics, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT) securities between March 10, 2021 and December 15, 2023 (the “Class Period”). Click Here to Join Investigation. … Read MoreJoin Investigation